www.SEFC.org

 
 
FARMACOVIGILANCIA / Normativa
 
Legislación Española
 
LEY 25/1990, de 20 de diciembre, del Medicamento. (B.O.E. 306 de 22 de diciembre de 1990).
Real Decreto 711/2002, de 19 de julio de 2002, por el que se regula la farmacovigilancia de medicamentos de uso humano.
Circular Nº 15/2002, de 30 de Septiembre de 2002. Procedimientos de comunicación en materia de farmacovigilancia de medicamentos de uso humano entre la Industria Farmacéutica y el Sistema Español de Farmacovigilancia de medicamentos de uso humano.
Real Decreto 223/2004, de 6 de Febrero, por el que se regulan los ensayos clínicos con medicamentos. Ministerio de Sanidad y Consumo.
REAL DECRETO 520/1999, de 3 1 de marzo, por el que se aprueba el Estatuto de la Agencia Española del Medicamento (B.O.E. 77 de 31 de marzo de 1999).
   
Normativa Europea
 
Volume 9 – Pharmacovigilance. Rules Governing Medicinal Products in the European Union, published by the European Commission, Directorate Enterprise, Regulatory Framework and Market Authorisations (Version December 2001)
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2002 on the Community Code relating to medicinal products for human use
Commission Regulation (EC) No 540/95 , of 10 March 1995, laying down the arrangements for reporting suspected unexpected adverse reactions which are not serious, whether arising in the Community or in a third country, to medicinal products for human or veterinary use authorized in accordance with the provisions of Council Regulation (EEC) No 2309/93.
Council Regulation (EEC) No 2309/93 , of 22 July 1993 , laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products. Amended by Commission Regulation (EC) No 649/98 of 23 March 1998 amending the Annex to Council Regulation (EEC) No 2309/93
   
Guías Europeas
 
EMEA/H/31387/01 Final Note for Guidance on Regulatory Electronic Transmission of Individual Case Safety Reports (ICSRs) in Pharmacovigilance (EudraVigilance TIG adopted March 2002)
CPMP/PHVWP/1618/01 Position Paper on Compliance with Pharmacovigilance Regulatory Obligations (Adopted November 2001)
http://www.emea.eu.int/pdfs/human/swp/016699en.pdf CPMP/PhVWP/2058/99 Revision 1 (EV-TIG) - Joint Pharmacovigilance Plan for the Implementation of the ICH E2B, M1 and M2 Requirements related to the Electronic Transmission of Individual Case Safety Reports in the Community (Submitted for Approval by CPMP, April 2001)

CXMP/PhVWP/2056/99 Note for Guidance on Electronic Exchange of Pharmacovigilance Information for Human and Veterinary Medicinal Products in the European Union

CPMP/PhVWP/005/96, Revision 1 - Note for Guidance on the Rapid Alert System (RAS) and Non-Urgent Information System (NUIS) in Human Pharmacovigilance

CPMP/PHVWP/175/95 Revision1 - Note for Guidance on Procedure for Competent Authorities on the Undertaking of Pharmacovigilance Activities (Revision adopted by CPMP Feb. 99)

CPMP/PHVWP/053/98 Principles of providing the World Health Organisation with Pharmacovigilance Information

CPMP/183/97 Conduct of Pharmacovigilance for Centrally Authorised Products

EMEA/H/15994/03 Communication addressed to all MAH in the EEA - Implementation of the Electronic Transmission of Individual Case Safety Report in the EEA

EMEA/h/5255/01/FINAL. Policy paper on the implementation of the Electronic Transmission of Individual Case Safety Reports for Medicinal Products for Human Use Authorised in the European Union.

CPMP/PhVWP/4838/02 Concept Paper on Conduct of Pharmacovigilance for Medicines used by Children

   
Guías de la Conferencia Internacional de Armonización (ICH)
 
Topic E1A Step 5 Note for Guidance on Population Exposure: The extent of Population Exposure to assess Clinical Safety (CPMP/ICH/375/95 adopted November 94)

Topic E2A Step 5 Note for Guidance on Good Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (CPMP/ICH/377/95 - adopted November 94)

Top i c E 2B(M) Step 5 Modification Note for Guidance on Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports (ICH ICSR DTD Version 2.3)(CPMP/ICH/287/95 - Mod. released for information November 2000)

 

Topic E 2B (M) Step 5 Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports- Questions and Answers. Release for information November 2003

Topic E2C Step 4 Note for Guidance on Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs (CPMP/ICH/288/95 - adopted December 96)

Topic V 1* Clinical Safety Data Management Periodic Safety Update Reports for Marketed Drugs (CPMP/ICH/4679/02 - final approval of addendum by CPMP February 2003) (Addendum to ICH E2C )
Topic E2D Post approval safety data management. Note for Guidance on Definition and Standards for Expedited Reporting (CPMP/ICH/3945/03 -Final approval by CPMP November 2003)

Topic E2E Pharmacovigilance Planning (PVP). Note for Guidance on Planning Pharmacovigilance Activities (CPMP/ICH/5716/03 - released for consultation November 03)

Topic M2 , Step 5 Modification Note for Guidance on Recommendations on Electronic Transmission of Individual Case Safety Reports Message Specification. (CPMP/ICH/285/95 - Mod. released November 2000) (Large file: 335KB)

   
OTROS DOCUMENTOS
 
Informe sobre los procedimientos de evaluación y control a emplear con los estudios de Post-Autorización
Buenas Prácticas de Farmacovigilancia para la Industria Farmacéutica. Ministerio de Sanidad y Consumo. 19 de julio de 2002
ENTR/F2/BL D(2003) Detailed guidance on the European database of Suspected Unexpected Serious Adverse Reactions (Eudravigilance – Clinical Trial Module. April 2003. European Commission.
ENTR/F2/BL D(2003) Detailed guidance on the collection, verification and presentation of adverse reaction reports arising from clinical trials on medicinal products for human use. April 2003. European Commission.

Lista de acrónimos habituales en farmacovigilancia

   
OTROS ENLACES DE INTERÉS
 
Agencia Española Medicamentos y Productos Sanitarios
Ministerio de Sanidad y Consumo
Directorio de Centros Autonómicos del Sistema Nacional de Farmacovigilancia

EMEA Agencia Europea para la Evaluación de Medicamentos.

F DA-CDER Food and Drug Administration, Center for Drug Evaluation and Research
Eudravigilance. Pharmacovigilance in the EU

European Commission - Enterprise DG - Pharmaceuticals : Regulatory framework and Market authorisations

MedDRA MSSO web site
BIFAP. Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria
Farmacovigilancia.com - Recopilación de la normativa autonómica sobre estudios post-autorización
WHO Drug Alert System
   
REVISTAS DE FARMACOVIGILANCIA
 
Pharmacoepidemiology and Drug Safety
Adverse Drug Reactions and Toxicological Review
   
OTRAS PÁGINAS DE FARMACOVIGILANCIA
 
Centre régional de Pharmacovigilance et de renseignements sur le médicament de Haute-Normandie
Sistema Nacional de Farmacovigilancia de Argentina